Clinical Trial: OEA for Young Adults With Alcohol Use Disorder

U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503782) titled 'OEA for Young Adults With Alcohol Use Disorder' on March 03.

Brief Summary: The goal of this clinical trial is to evaluate the effects of oleoylethanolamide (OEA) supplementation on inflammation, the oral microbiome, neurocognitive function, and alcohol use in young adults ages 18 to 25 with alcohol use disorder (AUD). The main questions it aims to answer are:

* Does OEA reduce peripheral markers of immune activation (IL-6, TNF-α, IL-1β, and LPS)?

* Does OEA alter oral microbiome composition?

* Does OEA improve neurocognitive measures of reward sensitivity and impulsivity?

Researchers will compare OEA to a placebo (a l...